Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Dolby Laboratories, Inc. (DLB) vs Symbotic Inc (SYM) Price & Performance

Dolby Laboratories, Inc.Trade
Symbotic IncTrade

Price performance (Past 24H)

Key statistics

Dolby Laboratories, Inc. vs Symbotic Inc — how do they compare? Dolby Laboratories, Inc. trades at $58.63 (market cap $5.47B), while Symbotic Inc trades at $42.6 (market cap $5.46B). The key difference: Dolby Laboratories, Inc. and Symbotic Inc are close in size by market cap, and Dolby Laboratories, Inc. pays a 2.46% dividend while Symbotic Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dolby Laboratories, Inc. for 98 Days and Symbotic Inc for 23 Days on average.

DLBSYM
Market Cap
$5.47B$5.46B
Volume
1,058,2841,965,805
Sector
TechnologyIndustrials
52-Week High
$70.09$87.30
52-Week Low
$48.51$38.22
Typical Hold Time
98 Days23 Days
Enterprise Value
$4.85B$3.72B
Dividend Yield
2.46%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Dolby Laboratories, Inc.

DLB trades at $58.90, up 0.94% with bearish technical signals but strong fundamentals including 87.61% gross margins and consistent earnings beats. Recent expansion with Meta and leadership transition to Marc Whitten highlight growth initiatives. Cash flow improved significantly to $215.61M in 2025 from negative trends.

Analyst consensus targets $90.33 (53% upside) with 47% buy ratings, though technical indicators signal caution. Key risks include licensing volatility and execution during leadership change. Revenue stability and premium valuation at 24.87 P/E support long-term case if growth accelerates.

Symbotic Inc

SYM trades at $42.73, down 1.34% today, with bearish technical signals dominating. The stock shows mixed fundamentals with strong revenue growth projected ($2.6B in 2026) but negative 2025 net income of -$16.94M. Recent earnings show two misses against expectations, though Q4 2025 beat estimates. Analyst consensus remains positive with 61% buy ratings and a $60.33 price target, representing 41% upside potential from current levels.

The outlook balances growth potential against execution risks. SYM's $22.5B backlog and expanding AI/robotics market position offer substantial upside, but customer concentration (85% Walmart revenue) and recent earnings misses create near-term uncertainty. Technical indicators suggest caution with bearish moving average signals, though oversold conditions may present entry opportunities for long-term investors.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DLB

No sentiment data available yet.

SYM
29% Buy71% Sell
Avg holding period · 23 Days

Top news

Latest headlines on both assets

About Dolby Laboratories, Inc.

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Read more on DLB →

About Symbotic Inc

Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.

Read more on SYM →